~~<i id='631712953B'><strike id='631712953B'><tt id='631712953B'><pre id='631712953B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：Wikipedia 2025-09-06 05:03:16 - browse：62

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： American taxpayers paid $1.8 trillion in health care costs in 2022

hotspot

focus

entertainment

focus

Wikipedia

focus

AdobeSANFRANCISCO—HospitalleadersspentagoodchunkoftheirstagetimeattheJ.P.MorganHealthcareConferencet

WSS

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Physician assistants need a new name. Here's what it should be

Stories you might have missed in 2023: health, science, medicine

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Argenx drug significantly slows progression of nerve disorder

Wikipedia

Wikipedia

hotspot

At least 13 dead in Texas as scorching temps continue

Hospital chaplains balance Covid safety with patients’ spiritual needs

As demand for Covid shots wanes, Moderna seeks its next success

Merck to acquire Harpoon Therapeutics for $680 million

After affirmative action ruling, medical educators look to 'holistic review'

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Wildfire smoke exposes gaps in outdoor worker protections

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Peter Hotez and the public health issue of online harassment

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

focus

Involuntary treatment for addiction doesn't work

Arena BioWorks launches in Cambridge to speed drug discovery

Study suggests new cause of Down syndrome: cells linked to aging

Medicare Advantage coverage denials need scrutiny, senators say

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Europe sees delivery challenges ahead on Alzheimer's therapies

entertainment

focus

Wikipedia

focus